Page 1 of Clinical Trials for Biological cytomegalovirus pp65-specific cytotoxic T lymphocytes, 3 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Last Updated: August 20, 2011
Condition(s): Cancer
2
Recruiting
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
Last Updated: August 18, 2011
Condition(s): Cancer
3
Active, not recruiting
Daclizumab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Last Updated: September 8, 2011
Condition(s): Brain and Central Nervous System Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+cytomegalovirus+pp65-specific+cytotoxic+T+lymphocytes

Page 1 of Clinical Trials for Biological cytomegalovirus pp65-specific cytotoxic T lymphocytes, 3 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About